Evidence map›Paper›PMID 29618935›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2018

Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases.

Rajan Singh, Shehla Pervin, Se-Jin Lee, Alan Kuo, Victor Grijalva, John David, Laurent Vergnes, Srinivasa T Reddy

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. The Effect of Exercise on Spexin and Follistatin in Elderly Individuals.Journal of cachexia, sarcopenia and muscle · 2025
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Activin Actions in Adipocytes.The Journal of clinical endocrinology and metabolism · 2025
    Review
  8. Article
  9. The role of hepatokines in NAFLD.Cell metabolism · 2023
    Review
  10. Mechanisms by Which Skeletal Muscle Myokines Ameliorate Insulin Resistance.International journal of molecular sciences · 2022
    Review
  11. Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People.International journal of environmental research and public health · 2021
    Review
  12. Hepatokines as a Molecular Transducer of Exercise.Journal of clinical medicine · 2021
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Rajan SinghDepartment of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, CA, USA.
Shehla PervinDepartment of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, CA, USA.
Se-Jin LeeThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Alan KuoDepartment of Biology, California State University Dominguez Hills, CA, USA.
Victor GrijalvaDepartment of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, CA, USA.
John DavidDepartment of Comparative Medicine, Pfizer Inc, San Diego, CA, USA.
Laurent VergnesDepartment of Human Genetics, UCLA School of Medicine, Los Angeles, CA, USA.
Srinivasa T ReddyDepartment of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, CA, USA.
University of California, Los Angeles · USCalifornia State University, Dominguez Hills · USPfizer (United States) · USUniversity of Connecticut · US

Funding

Sustaining Faculty Development & Community EngagementS21MD000103 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CARLISLE, DAVID M · 2001 to 2015
$73.9M
MBRS RISE at CSU Dominguez HillsR25GM062252 · NIGMS · CALIFORNIA STATE UNIV-DOMINGUEZ HILLS · PI MARTINEZ, HERNAN LEONARDO · 2001 to 2020
$7.3M
The role of PON2 and PON3 proteins in AtherosclerosisR01HL071776 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REDDY, SRINIVASA T. · 2003 to 2017
$4.8M
Characterization of Myostatin and GDF-11R01AR060636 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LEE, SE-JIN · 2010 to 2020
$3.7M
Targeting pERK1/2 in Human Mammary Cancer Stem CellsSC1CA165865 · NCI · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI PERVIN, SHEHLA · 2011 to 2015
$1.4M
Follistatin promotes browning and influences energy metabolismSC1AG049682 · NIA · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI SINGH, RAJAN · 2014 to 2017
$1.1M
NCI NIH HHS SC1 CA165865NHLBI NIH HHS R01 HL071776NIAMS NIH HHS R01 AR060636NIA NIH HHS SC1 AG049682NIGMS NIH HHS R25 GM062252NIMHD NIH HHS S21 MD000103
6 · The paper itself

Abstract

backgroundFollistatin (Fst) promotes brown adipocyte characteristics in adipose tissues.

methodsAbdominal fat volume (CT scan), glucose clearance (GTT test), and metabolomics analysis (mass spectrometry) of adipose tissues from Fst transgenic (Fst-Tg) and wild type (WT) control mice were analyzed. Oxygen consumption (Seahorse Analyzer) and lipidomics (gas chromatography) was analyzed in 3T3-L1 cells.

resultsFst-Tg mice show significant decrease in abdominal fat content, increased glucose clearance, improved plasma lipid profiles and significant changes in several conventional metabolites compared to the WT mice. Furthermore, overexpression of Fst in 3T3-L1 cells resulted in up regulation of key brown/beige markers and changes in lipidomics profiles.

conclusionFst modulates key factors involved in promoting metabolic syndrome and could be used for therapeutic intervention.

Indexed as

adipocyteAdipoQfibroblast growth factor 21follistatintransgenic

Identifiers

PMID29618935
PMCPMC5875402
OpenAlexW2790756708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.